Recombinant SMN protein synergizes with spinal muscular atrophy therapy to counteract pathological motor neuron phenotypes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Recombinant SMN protein synergizes with spinal muscular atrophy therapy to counteract pathological motor neuron phenotypes ; volume:13 ; number:1 ; day:17 ; month:12 ; year:2024 ; pages:1-5 ; date:12.2024
Translational neurodegeneration ; 13, Heft 1 (17.12.2024), 1-5, 12.2024
- Urheber
-
Brambilla, Liliana
Valori, Chiara F.
Guidotti, Giulia
Martorana, Francesca
Sulmona, Claudia
Martini, Lisa Benedetta De
Canciani, Anselmo
Fumagalli, Marco
Talpo, Francesca
Biella, Gerardo
Pasquale, Elisa Di
Iacobucci, Claudio
Forneris, Federico
Zhou, Haiyan
Rossi, Daniela
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40035-024-00455-4
- URN
-
urn:nbn:de:101:1-2502282102111.368955645278
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Brambilla, Liliana
- Valori, Chiara F.
- Guidotti, Giulia
- Martorana, Francesca
- Sulmona, Claudia
- Martini, Lisa Benedetta De
- Canciani, Anselmo
- Fumagalli, Marco
- Talpo, Francesca
- Biella, Gerardo
- Pasquale, Elisa Di
- Iacobucci, Claudio
- Forneris, Federico
- Zhou, Haiyan
- Rossi, Daniela
- SpringerLink (Online service)
Ähnliche Objekte (12)
Spinal muscular atrophy
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Advances in treatment of spinal muscular atrophy – new phenotypes, new challenges, new implications for care
Muscle contractility in spinobulbar muscular atrophy
Very severe spinal muscular atrophy (Type 0)
Disease burden of spinal muscular atrophy in Germany
Choosing Life with Spinal Muscular Atrophy Type 1
Therapeutic advances in 5q-linked spinal muscular atrophy
Pattern of pareses in 5q-spinal muscular atrophy
SMN1dosage analysis in spinal muscular atrophy from India
Growth patterns in children with spinal muscular atrophy
Spinal muscular atrophy
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Advances in treatment of spinal muscular atrophy – new phenotypes, new challenges, new implications for care
Muscle contractility in spinobulbar muscular atrophy
Very severe spinal muscular atrophy (Type 0)
Disease burden of spinal muscular atrophy in Germany
Choosing Life with Spinal Muscular Atrophy Type 1
Therapeutic advances in 5q-linked spinal muscular atrophy
Pattern of pareses in 5q-spinal muscular atrophy
SMN1dosage analysis in spinal muscular atrophy from India
Growth patterns in children with spinal muscular atrophy
Spinal muscular atrophy
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Advances in treatment of spinal muscular atrophy – new phenotypes, new challenges, new implications for care
Muscle contractility in spinobulbar muscular atrophy
Very severe spinal muscular atrophy (Type 0)
Disease burden of spinal muscular atrophy in Germany
Choosing Life with Spinal Muscular Atrophy Type 1
Therapeutic advances in 5q-linked spinal muscular atrophy
Pattern of pareses in 5q-spinal muscular atrophy
SMN1dosage analysis in spinal muscular atrophy from India